Interstitial Lung Disease Spotlight-Gathering Together: Recognition and Treatment of Progressive Fibrotic Interstitial Lung Disease

Gathering Together: Recognition and Treatment of Progressive Fibrotic Interstitial Lung Disease

Video Transcription

Video Summary

The video transcript discusses the topic of progressive pulmonary fibrosis, also referred to as progressive pulmonary fibrosis (PPF). The session highlights the new progressive pulmonary fibrosis namesake and aims to characterize the patients with this condition. The speaker provides an overview of the prevalence and diagnosis of progressive interstitial lung disease. They discuss the importance of diagnosing and managing progressive pulmonary fibrosis, as well as the markers and criteria used for diagnosis. The speaker also shares information on various treatment options, including immunosuppression and antifibrotic therapies, and the role of genetics and biomarkers in predicting patient outcomes. Additionally, they touch on the use of proteomics, blood cell count differentials, and imaging as potential biomarkers for assessing disease progression and prognosis. The presentation emphasizes the need for further research in order to develop more effective treatment strategies and improve patient outcomes.

Meta Tag

Category Diffuse Lung Disease

Speaker Tejaswini Kulkarni, MD, MBBS, FCCP

Speaker Brad Bemiss, MD, BS

Speaker Ayodeji Adegunsoye, MD, FCCP

Keywords

progressive pulmonary fibrosis

PPF

diagnosis

treatment options

genetics

biomarkers

prognosis

research

patient outcomes